Enfusion, Inc.
ENFN
ENFN was delisted on the 17th of April, 2025.
83 hedge funds and large institutions have $892M invested in Enfusion, Inc. in 2023 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 24 reducing their positions, and 23 closing their positions.
103% more call options, than puts
Call options by funds: $1.99M | Put options by funds: $981K
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
33% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 24
10% more capital invested
Capital invested by funds: $813M → $892M (+$78.6M)
8% less funds holding
Funds holding: 90 → 83 (-7)
30% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.5M |
| 2 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
+$11.1M |
| 3 |
ICM
Irenic Capital Management
New York
|
+$10.6M |
| 4 |
FMC
FTV Management Company
San Francisco,
California
|
+$10.1M |
| 5 |
1WCM
12 West Capital Management
New York
|
+$7.56M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DIG
Dragoneer Investment Group
San Francisco,
California
|
-$44.3M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$3.06M |
| 3 |
JP Morgan Chase
New York
|
-$2.75M |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$1.4M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.22M |
ENFN Hedge Fund Activity: Q2 2023 in Review
83 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Enfusion, Inc. (ENFN) for Q2 2023, worth a combined $892M — up 9.7% from $813M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of ENFN and 16 opened new positions — a net loss of 7 holders — while 24 trimmed existing stakes and 32 added.
The largest buyer was Vanguard Group, adding an estimated $11.5M. The largest seller was Dragoneer Investment Group, exiting entirely with an estimated $44.3M sold.
- 83 institutional investors held Enfusion, Inc. (ENFN) as of Q2 2023, down from 90 in Q1 2023.
- Funds reported $892M of Enfusion, Inc. stock for Q2 2023, up 9.7% quarter-over-quarter.
- 16 funds opened new Enfusion, Inc. positions in Q2 2023 and 23 closed out, a net change of -7 holders.
- The largest Enfusion, Inc. buyer in Q2 2023 was Vanguard Group, an estimated $11.5M added.
- The largest Enfusion, Inc. seller in Q2 2023 was Dragoneer Investment Group, an estimated $44.3M sold.
Based on aggregated 13F filings for Q2 2023.